We monitored the consumption of NADPH when H 2 O 2 was added to the Trx/Trr/NADPH redox system.
Figure S1.
Time-dependent oxidation of NADPH by H 2 O 2 . (A) Tsa1 (complete; pink diamonds) but not Yap1 (no Tsa1 but Yap1; blue triangles) in the Trx/Trr/NADPH system plus H 2 O 2 induced the oxidation of NADPH.
Results for reactions with only the Trx/Trr/NADPH system (no Tsa1; yellow triangles) and without H 2 O 2 (no H 2 O 2 ; blue squares) are also shown. (B) Reactions in the presence of Gpx3 (complete; pink diamonds), but not in its absence (no Gpx3; yellow triangles) in the Trx/Trr1/NADPH system plus H 2 O 2 resulted in the oxidation of NADPH. Results for reactions with Gpx3/Trr1/NADPH (no Trx; light blue crosses), NADPH and H 2 O 2 (purple asterisks); NADPH only (brown circles); and without H 2 O 2 (no H 2 O 2; blue squares) are also shown.
Figure S2
MALDI-TOF mass spectrometry of Yap1 (red), Yap1 (oxI) and Yap1 (oxII). We purified Yap1 (red), Yap1 (oxI) and Yap1 (oxII), which had been generated in the in vitro system. We analyzed peptide fragments of Yap1 (red) (A) , Yap1 (oxI) (B) and Yap1 (oxII) (C).
Distinct Midpoint Redox Potentials of Oxidized Forms of Yap1
The results in the main text suggested that the oxidation of Yap1 might involve several bidirectional redox reactions that respond to fluctuating levels of NADPH and H 2 O 2 . We postulated that the midpoint redox potential of Yap1 might change from one oxidized form to the next. We examined midpoint redox potentials of various forms of oxidized Yap1, Gpx3 and Trx2 in our in vitro redox system. First we determined the midpoint redox potential (E' 0 ) of Trx2 using α-lipoic acid and dihydrolipoic acid (6,8-thioctic acid) as a calibrating redox buffer (lipoate redox buffer; E' 0 = −290 mV; Lamoureux and Whitesides [1993] ). We examined the ratio of the oxidized to the reduced form (ox/red) at redox equilibrium at different ratios of oxidized to reduced lipoate ( Figure S3A ). We found that the midpoint redox potential of Trx2 was −262 mV at pH 7.0 and 25°C (SD = 0.64; n = 3). Because we failed to oxidize and reduce Yap1 and Gpx3 in the lipoate redox buffer (data not shown), we examined the ox/red ratios of Trx2, Gpx3, and Yap1 at a redox equilibrium that depended on the balance between H 2 O 2 and NADPH. After Yap1 and mutants of Yap1 had been oxidized in the Gpx3/Trx2/Trr1/NADPH system with H 2 O 2 , we titrated each reaction mixture with NADPH at various concentrations (see Figure 4A in the main text). First we examined the redox potential of Gpx3 (−254 mV; n = 2: −254.1 and −253.0) as it related to the ox/red ratio of Trx2 ( Figure S3B ). As shown in Figure 4A in the main text, the ox/red ratios of these Yap1 proteins varied with the ox/red ratio of Gpx3. We calculated the redox potential of each The redox potential of the Yap1 redox domain was reported recently by Mason et al. (2006) . The discrepancy between their result and ours might be due to differences in the redox buffer systems used and in the Yap1 domain used for the assays. Mason et al. determined the reduction state of a peptidase-resistant redox domain of Yap1 using DTT in their redox buffer system. Since the peptidase-resistant domain consists of two disconnected domains, n-CRD and c-CRD, the titration reaction might be irreversible. Furthermore, Cys315 was missing from the redox domain. We found that redox reactions in Gpx3 (Orp1) and Yap1 in lipoate buffer were inefficient; therefore we used a physiological redox system (H 2 O 2 /Gpx3/Trx2/Trr1/NADPH) in the analysis of Gpx3, Yap1 and mutant forms of Yap1. 
Supplemental Experimental Procedures

Construction of Plasmids
Two regions of the Yap1 protein were expressed in Escherichia coli. Genes encoding the entire regulatory domain of Yap1 (amino acid residues 122 to 650) or the n-CRD region (amino acid residues 122 to 373)
were cloned between the SmaI and SalI sites of the pGEX-6P2 vector (GE Healthcare, Amersham Place, UK), and the resulting expression vectors were designated as pGEX-YAP1 and pGEX-n-CRD, respectively. For construction of the plasmid that expressed mutant Yap1 proteins in bacteria, the MfeI-SalI fragment of each pRS314 cp-GFP HA YAP1 mutant (see below) was used to replace the corresponding fragment in pGEX-YAP1. pET-TRX2 (Izawa et al. 1999 ) was used to express Trx. The open reading frames of GPX3, TSA1 and TRR1 were amplified by PCR from yeast genomic DNA and cloned into pET-15b (Novagen; EMD Biosciences, Darmstadt).
To construct a yeast expression vector for full-length Yap1 tagged with a triplicate HA-tag ([HA] 3 -tag) at the amino-terminal region of Yap1, a coding sequence of a duplicate HA-tag was inserted into pRS314 cp HA YAP1 (Kuge et al., 1997 into the pRS314 cp vector (Kuge et al., 1997) and inserted coding sequences of an (HA) 3 -tag or a (myc) 9 -tag (Delaunay et al., 2000) at the amino-terminal region of the Yap1. For expression of myc-tagged Yap1, the plasmid vector was replaced by pRS315 (Sikorski and Hieter, 1989) .
Expression and Purification of Recombinant Proteins
E. coli BL21 (DE3) was transformed with the indicated expression vector. Cultures of the transformant in L-broth at the logarithmic phase (OD 600 = 0.5) were treated with 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG) for 3.5 h at 30°C to induce expression of fusion proteins.
Cells were collected and lysed by sonication in PBS that contained 1 mM DTT. After centrifugation of lysates at 15,900g for 20 min at 4°C, each recombinant Yap1 protein, fused to glutathione S-transferase (GST), was purified from the supernatant on GSH-Sepharose (GE Healthcare) as described by Kuge et al. (2001) . The GST-fused Yap1 proteins were released by cleavage of GST from each protein by PreScission Protease™ (GE Healthcare) according to the manufacturer's instructions. The recombinant Yap1 proteins were reduced by treatment with 10 mM DTT for 15 min, and then DTT was removed by gel-filtration column chromatography on NAP5 (GE Healthcare), with subsequent concentration using Vivaspin™ (Sartorius, Göttingen). For purification of polyhistidine-tagged (His-tagged) proteins, E. coli cells were lysed by sonication in buffer A (300 mM NaCl, 50 mM NaH 2 PO 4 , 10 mM imidazole, pH 8.0). His-tagged proteins (Gpx3, Tsa1, Trx2, and Trr1) were then purified by two cycles of chromatography on a column of Ni-nitrilotriacetic acid (Ni-NTA) agarose (Qiagen, Düssendorf) according to the manufacturer's instructions. Proteins were quantified by Bradford's method with the use of a Protein Assay kit (Bio-Rad Laboratories, Hercules, CA) with BSA as the standard.
Time-Dependent Consumption of NADPH
Time-dependent consumption of NADPH in the Prx (Gpx3 or Tsa1)/Trx2/Trr1/NADPH redox system was monitored as follows. We added 0.25 mM NADPH to a 500-μl reaction mixture that contained 2.1 μM Gpx3 (or Tsa1), 0.45 μM Trx2 and 0.15 μM Trr1 in 40 mM HEPES-NaOH buffer (pH 7.0). After addition of 0.5 mM H 2 O 2 , we monitored absorbance of NADPH at 340 nm at 1-min intervals for 30 min with a spectrophotometer (DU640; Beckman Coulter, Fullerton, CA).
Analysis of Yap1 by Mass Spectrometry
Yap1 (oxI) and Yap1 (oxII) were prepared after oxidation of Yap1 (red) by 0.4 mM H 2 O 2 in the Gpx3/Trx2/Trr1/NADPH redox system for 15 sec and 5 min, respectively, and fixation with IAA as described above. The level of Yap1 (oxI) and Yap1 (oxII) were elevated under these oxidation conditions ( Figure 3B ). Yap1 (oxI) and Yap1 (oxII) were purified by preparative SDS-disk gel electrophoresis (Nihon Eido, Tokyo, Japan). Yap1 (oxI) and Yap1 (oxII) were further purified by MonoQ™ and fast desalting column chromatography using a SMART™ system (GE Healthcare). 500 nM of Yap1 (oxI) was digested with 1 pmol of lysyl endopeptidase (Wako Pure Chemical, Osaka, Japan) in 70% acetonitorile and 10 mM IAA at 37°C for 16 h. Half of the sample was reduced by heating with 2.5 mM DTT at 100°C for 5 min and was then alkylated with 10 mM IAA. After purification with a C18 Zip-tip (Millipore, Billerica, MA), the resulting peptides were mixed with α-cyano-4-hydroxycinnamic acid (in 50% acetonitrile and 0.1% trifluoroacetic acid). Peptides were analyzed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry on a Voyager-ATR system (Applied Biosystems, Foster City; Figures 2D and 2E ) or an AXIMA-CFR (Shimazu corporation, Kyoto, Japan; Figure S2 ) with angiotensin II and ACTH as internal controls.
Redox Titration of Yap1 and Yap1 Mutants
We performed a redox titration of NADPH in the Trx/Trr/NADPH redox system. The reaction mixture contained 22.5 μM Gpx3, 4.82 μM Trx2, 1.61 μM Trr1 and 0.4 mM NADPH and was incubated at room temperature for 30 min to reduce the entire system. After addition of 5 μg of reduced and concentrated Yap1 protein to the reaction mixture, H 2 O 2 was added to a final concentration of 0.4 mM, and incubation was continued for 60 min, by which time the reaction had reached equilibrium. The samples were then divided into tubes that contained various amounts of NADPH (final concentrations of 0.44, 0.48, 0.52, 0.56, 0.60 and 0.64 mM), and the samples were incubated for another hour to until they again reached equilibrium. The redox reactions were stopped by the addition of AMS as described in the main text, and the reduced and oxidized forms of each protein were quantified after SDS-PAGE and staining with 0.1%
Coomassie brilliant blue R-250 (Sigma-Aldrich, St. Louis), as described in the main text.
Determination of Midpoint Redox Potentials of Recombinant Proteins
Recombinant Trx2 (1 μM; after removal of the His-tag by digestion with thrombin) was redox-titrated in degassed HEPES buffer (75 mM HEPES-NaOH, pH 7.0; 125 mM KCl, 1 mM EDTA) that contained 10 mM lipoate as redox buffer essentially as described previously (Dooley et al., 2004) . Reaction mixtures were incubated at room temperature (25°C) for 1 h under argon and/or nitrogen, and then the oxidized and reduced proteins were analyzed by SDS-PAGE after free thiols had been allowed to react with AMS, as described in the main text. We obtained fluorescent images of the gels using Flamingo gel stain (Bio-Rad) and the VarsaDoc™ imaging system (Bio-Rad). We quantitated oxidized and reduced proteins using Quantity One ® software (Bio-Rad).
We first determined the ox/red ratio of Trx2 in lipoate (K eq ) buffer to achieve a 50% change in ratio for the recombinant protein, which we determined from the intercept, where log 10 X = 0, on a graph on which 
where E' 0 is the redox potential of lipoate (−290 mV), R is the gas constant (8.313 J/mol/K), T is the temperature (K), n is the number of electrons exchanged (=2) and F is Faraday's constant (96,490 J mol
To determine the midpoint redox potentials, we first quantitated the decreasing levels of oxidized Yap1
CTT,CAT , n-CRD) and Gpx3 (Figure 4 of main text), and then we determined the ox/red ratio of Gpx3 by applying the following formulas at each concentration of 
Yap1
n is the level of Yap1 (oxII) or n-CRD (ox) in each of the reactions. We determined the relative level of Gpx3 (K eq ) needed to achieve a 50% changed in the ox/red ratio of each Yap1 protein Roche Diagnostics) at a ratio of 1 μg of total protein to 0.5 U of CIAP. Then lysates were fractionated by electrophoresis on a 7.5%-17.5% gradient polyacrylamide gel (for analysis of Yap1 and Gpx3) or on a 15% polyacrylamide gel (for analysis of Trx and Tsa1). To examine the redox status of Trx, we treated the above-described lysates with DTT (final concentration: 20 mM) for 30 min and then incubated them with AMS as described above. To determine the redox status of Trx1 and Tsa1, we fractionated samples on an SDS-polyacrylamide gel (15% polyacrylamide; ratio of acrylamide to bis-acrylamide of 29:1) in a Tris-Tricine buffer system (Daiichi Pure Chemicals, Tokyo, Japan) under non-reducing conditions. We performed Western blotting and detection of HA-tagged Yap, myc-tagged Yap1, Trx2 and Gpx3 as described elsewhere (Kuge et al., 1997) . We used monoclonal antibodies specific for HA-tag (Roche Diagnostics) and myc-tag (Sigma-Aldrich) and rabbit antiserum raised against yeast Trx2 that reacted with both Trx2 and Trx1 (Izawa et al., 1999) . We immunized rabbits with Gpx3 and Tsa1 purified from bacteria and isolated polyclonal antibodies specific for Gpx3 and Tsa1, respectively. We obtained the chemiluminescent images of the filter using Immobilon Western Chemiluminescent HRP Substrate (Millipore) and the VarsaDoc™ imaging system (Bio-Rad).
Fluorescence Microscopy
We examined the fluorescence of green fluorescent protein (GFP) in live yeast cells that had been attached to glass-based dishes (Asahi Techno Glass, Tokyo, Japan) coated with concanavalin A (Sigma-Aldrich) at 30°C using a Dmire-2 microscopes (Leica, Wetzlar, Germany) equipped with a GFP:S filter block and a CoolSNAP HQ™ camera (Roper Scientific, Duluth, GA). We analyzed images using the MetaMorph® imaging system (Molecular Devices, Sunnyvale, CA).
Micro-colony assay
Yeast cells at the logarithmic phase of growth were treated with H 2 O 2 . After gentle sonication, the cells were plated on YPD agar and cultured at 30°C for 9 h. Micro-colonies and non-divided cells on the agar plates were counted under a light microscope to calculate viability.
Northern blotting analysis
We prepared total RNA from yeast cells using the acid phenol method as described by Gasch et al. (2000) .
